“…Thus, the magnitude of BMP signaling is tightly regulated in the SVZ stem cell niche, such as by the BMP inhibitor noggin, which can be released from ependymal cells to control NSPC behavior (Lim et al , ). During CNS disease with vascular damage, extracellular environmental changes, such as the leakage of vascular system components (Schachtrup et al , ), as well as growth factor and cytokine abundance (Hampton et al , ; Schachtrup et al , ; Xiao et al , ; Logan et al , ; Schildge et al , ) are thought to modify NSPC fate. However, transcriptional changes evoked by the altered NSPC environment in CNS disease remain poorly characterized.…”